Kristopher Bosse, MD, attending physician, Division of Oncology, The Children's Hospital of Philadelphia, discusses the use of immunotherapy in the treatment of pediatric patients with cancer.
Kristopher Bosse, MD
Advertisement
Articles by Kristopher Bosse, MD
Kristopher Bosse, MD, attending physician, Division of Oncology, The Children's Hospital of Philadelphia, discusses challenges with immunotherapy in pediatric cancers.
Kristopher Bosse, MD, attending physician, Division of Oncology, The Children's Hospital of Philadelphia, discusses the treatment of pediatric patients with high-risk neuroblastoma.
Advertisement
Latest Updated Articles
Dr. Bosse on the Treatment of Neuroblastoma in Pediatric PatientsPublished: April 24th 2018 | Updated:
Dr. Bosse on Challenges With Immunotherapy in Pediatric CancersPublished: August 9th 2018 | Updated:
Dr. Bosse on Immunotherapy in Pediatric CancersPublished: September 6th 2018 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
The OncFive: Top Oncology Articles for the Week of 1/25
3
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
4
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
5